The efficacy and safety of palbociclib combined with endocrine therapy in patients with hormone receptor-positive HER2-negative advanced breast cancer: a multi-center retrospective analysis

To explore the efficacy and safety of palbociclib combined with endocrine therapy (ET) in advanced breast cancer (ABC). We conducted a retrospective study involving patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) ABC who received palbocicli...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linhui, Song, Guohong, Shao, Bin, Xu, Ling, Xiao, Yu, Wang, Mopei, Sumou, Ingrid Karmane, Zhang, Yan, Liang, Xu, Jiang, Hanfang, Li, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670355/
https://www.ncbi.nlm.nih.gov/pubmed/34371506
http://dx.doi.org/10.1097/CAD.0000000000001210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670355/
https://www.ncbi.nlm.nih.gov/pubmed/34371506
http://dx.doi.org/10.1097/CAD.0000000000001210

Ejemplares similares